Method | Tissue sampled | Sensitivity | Specificity | Advantages | Disadvantages |
---|---|---|---|---|---|
Virus isolation by cell culture1 | Skin/mucosal lesions (stage): | Â | Â | Â | Specialized laboratories |
 |    - vesicular content | >90% |  | Gold standard | Virus transport medium |
 |    - ulcers | 95% | ~100% | Simplicity of sampling | Transport rapid, cooled, protected from light |
 |    - scabs | 70% |  | Virus typing | Results in 2/7 days |
 |    - mucosa without lesions | 30% |  | Resistance phenotype determination | Not suitable for CFS |
 |  | Unknown |  |  | Arrangement with laboratory necessary |
 | Biopsies |  |  |  |  |
 | Conjunctival smear/corneal |  |  |  |  |
 | Neonates |  |  |  |  |
Cytologic diagnosis (Tzanck's smear)35 | Skin/mucosal lesions | 73–100% | 100% | Easy, quick, reproducible and inexpensive | Optimal lesions are fresh, intact bisters of 1/3 days' duration |
 | Biopsies |  |  |  |  |
 | Conjunctival smear/corneal |  |  |  |  |
IF (detection of infected cells)30 | Smears, tissue sections, smears from base of vesicle | 41–70% | >95% | Rapid (<4 h possible) Typing possible | Fresh vesicles |
 |  |  |  |  | Specialised laboratories |
 |  |  |  |  | Technically demanding |
 |  |  |  |  | Not standardized |
Virus antigen detection by EIA o ELISA30 | Smears from lesions, vesicular content with base of vesicle | 41–80% | 80% | Simplicity of sampling | Suitable only for fresh vesicles |
 |  |  |  | Does not require the integrity of the specimen |  |
 |  |  |  | Rapid (<4 h possible) |  |
 |  |  |  | Typing possible |  |
 |  |  |  | PCR: |  |
 |  |  |  | Most sensitive method |  |
Virus DNA detection by PCR30 or Real-time PCR31 | CSF | 9798% | ~100% | Result within 24–48 h | Only in specialised laboratories |
 | Aqueous or vitreous humour |  |  | Virus typing and resistance genotyping | Not standardised |
 |  |  |  | Method of choice for CSF | Not validated for all samples |
 |  |  |  |  | Risk of contamination (PCR) |
 |  |  |  | Real-time PCR: | High costs (real-time PCR) |
 | Skin lesions, vesicular content or mucosa without lesions |  |  | Rapid amplification |  |
 |  |  |  | Quantitative analysis |  |
 |  |  |  | Reduced risk of contamination |  |
 |  |  |  | Method of choice for skin lesions |  |